Alpha Teknova (TKNO) Total Current Liabilities (2020 - 2026)
Alpha Teknova (TKNO) posted quarterly Total Current Liabilities of $6.9 million for Q1 2026, down 2.11% year-over-year from $7.0 million in Q1 2025, and down 8.5% quarter-over-quarter from $7.5 million in Q4 2025.
Alpha Teknova (TKNO) Total Current Liabilities (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Total Current Liabilities for 7 consecutive years, with $6.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 2.11% year-over-year to $6.9 million; the TTM figure through Mar 2026 stood at $6.9 million (down 2.11% YoY), while the FY2025 annual figure was $7.5 million, down 32.77% from the prior year.
- Total Current Liabilities retreated to $6.9 million in Q1 2026 per TKNO's latest filing, from $7.5 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $28.7 million in Q2 2023 and bottomed at $6.5 million in Q2 2025.
- Historically, Total Current Liabilities has averaged $10.1 million across 5 years, with a median of $8.7 million in 2023.
- Annual changes were most pronounced in 2023 — Total Current Liabilities surged 141.48% — and 2024, when it plunged 74.13%.
- Alpha Teknova's Total Current Liabilities stood at $10.9 million in 2022, then slipped by 18.39% to $8.9 million in 2023, then gained by 26.32% to $11.2 million in 2024, then plunged by 32.77% to $7.5 million in 2025, then retreated by 8.5% to $6.9 million in 2026.
- Business Quant data shows TKNO's Total Current Liabilities at $6.9 million in Q1 2026, $7.5 million in Q4 2025, and $6.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.79 Bn |
| 10 | Alpha Teknova | 374.37 Mn | 356.94 Mn | 4.89 Mn | 6.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.87 Mn |
| Mar 31, 2026 | 6.90 Mn |
| Dec 31, 2025 | 7.54 Mn |
| Sep 30, 2025 | 6.94 Mn |
| Jun 30, 2025 | 6.48 Mn |
| Mar 31, 2025 | 7.05 Mn |
| Dec 31, 2024 | 11.21 Mn |
| Sep 30, 2024 | 9.72 Mn |
| Jun 30, 2024 | 7.41 Mn |
| Mar 31, 2024 | 7.04 Mn |
| Dec 31, 2023 | 8.88 Mn |
| Sep 30, 2023 | 8.34 Mn |
| Jun 30, 2023 | 28.65 Mn |
| Mar 31, 2023 | 8.65 Mn |
| Dec 31, 2022 | 10.88 Mn |
| Sep 30, 2022 | 12.33 Mn |
| Jun 30, 2022 | 11.87 Mn |
| Mar 31, 2022 | 12.64 Mn |
| Dec 31, 2021 | 7.74 Mn |
| Sep 30, 2021 | 6.20 Mn |